Could Anti-Erythropoietin Receptor Antibodies Be the Future Management of Beta Thalassemia Intermedia?
Abstract
N/A
J Hematol. 2016;5(4):151-153
doi: https://doi.org/10.14740/jh285w
![]() | Journals | Policy | Permission |
This journal has moved to jh.elmerpub.com Please go to the new site to make submissions |
Journal of Hematology |